Biomarin Pharmaceutical (BMRN) Current Taxes (2010 - 2019)

Biomarin Pharmaceutical (BMRN) has 10 years of Current Taxes data on file, last reported at $11.4 million in Q1 2019.

• Quarterly Current Taxes changed N/A year-over-year to $11.4 million in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $11.4 million (changed N/A YoY) and the FY2018 annual result came in at $7.8 million, down 20.07% from the prior year.
• Current Taxes grew to $11.4 million in Q1 2019, from $7.8 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $11.4 million in Q1 2019 to a low of $2.7 million in Q2 2018.
• A 5-year average of $7.9 million and a median of $8.0 million in 2016 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2015 — Current Taxes surged 132.38% — and 2018, when it slumped 69.13%.
• Tracing BMRN's Current Taxes over 5 years: stood at $6.4 million in 2015, then gained by 23.07% to $7.8 million in 2016, then increased by 24.11% to $9.7 million in 2017, then declined by 20.07% to $7.8 million in 2018, then surged by 45.81% to $11.4 million in 2019.
• The last three Current Taxes figures came in at $11.4 million (Q1 2019), $7.8 million (Q4 2018), and $2.7 million (Q2 2018), per Business Quant data.